|
Volumn 10, Issue 2, 2007, Pages 61-63
|
Recent FDA warning of the concomitant use of aspirin and ibuprofen and the effects on platelet aggregation.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
IBUPROFEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
THROMBOXANE A2;
BLOOD;
DRUG EFFECT;
DRUG INTERACTION;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
STANDARD;
THROMBOCYTE AGGREGATION;
UNITED STATES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASPIRIN;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE INHIBITORS;
DRUG INTERACTIONS;
HUMANS;
IBUPROFEN;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
THROMBOXANE A2;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 34447532424
PISSN: 1520037X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1520-037X.2007.06496.x Document Type: Editorial |
Times cited : (10)
|
References (0)
|